Campbell & Co Investment Adviser’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$381K Sell
7,380
-1,840
-20% -$129K 0.02% 820
2025
Q4
$850K Buy
9,220
+6,480
+236% +$620K 0.04% 624
2025
Q3
$203K Sell
2,740
-2,848
-51% -$288K 0.02% 1004
2025
Q2
$725K Buy
5,588
+3,836
+219% +$556K 0.05% 641
2025
Q1
$279K Buy
1,752
+311
+22% +$56.3K 0.02% 866
2024
Q4
$267K Buy
+1,441
New +$280K 0.02% 880
2024
Q3
Sell
-2,026
Closed -$271K 1213
2024
Q2
$271K Buy
+2,026
New +$383K 0.02% 864
2023
Q4
Sell
-11,115
Closed -$2.21M 1202
2023
Q3
$2.21M Buy
11,115
+9,247
+495% +$2.33M 0.26% 69
2023
Q2
$606K Sell
1,868
-3,959
-68% -$1.13M 0.11% 334
2023
Q1
$1.36M Sell
5,827
-236
-4% -$59.7K 0.25% 81
2022
Q4
$1.53M Buy
6,063
+4,822
+389% +$1.03M 0.37% 26
2022
Q3
$220K Sell
1,241
-1,037
-46% -$208K 0.05% 588
2022
Q2
$416K Buy
2,278
+329
+17% +$65.6K 0.11% 337
2022
Q1
$500K Sell
1,949
-151
-7% -$34.5K 0.13% 278
2021
Q4
$483K Buy
2,100
+700
+50% +$171K 0.17% 212
2021
Q3
$326K Buy
+1,400
New +$292K 0.11% 352

Other funds holding INSP

Campbell & Co Investment Adviser's INSP Position: Q1 2026 in Review

Campbell & Co Investment Adviser reduced its Inspire Medical Systems (INSP) stake by 20% in Q1 2026, selling an estimated $129K and leaving 7,380 shares worth $381K. The position accounts for 0.02% of the portfolio, ranked #820.

Campbell & Co Investment Adviser first reported a position in INSP in Q3 2021 and has held it in 16 quarters since. The position peaked at $2.21M in Q3 2023. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Campbell & Co Investment Adviser held 7,380 shares of Inspire Medical Systems worth $381K as of Q1 2026.
  • Campbell & Co Investment Adviser sold 1,840 Inspire Medical Systems shares in Q1 2026, an estimated $129K.
  • Inspire Medical Systems made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #820 holding.
  • Campbell & Co Investment Adviser first reported a position in Inspire Medical Systems in Q3 2021 and has held it in 16 quarters since.
  • Campbell & Co Investment Adviser's Inspire Medical Systems position peaked at $2.21M in Q3 2023.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.